William Blair Downgrades Allergan To Market Perform

Analysts at William Blair downgraded Allergan

from Outperform to Market Perform. The price target for Allergan is set to $219. Allergan shares have gained 113.25% over the past 52 weeks, while the S&P 500 index has surged 14.18% in the same period. Allergan's shares fell 0.08% to $209.03 in after-hours trading.